Alessandro Villa, DDS, PhD, MPH

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Merck
    Topic:
    Consultant on HPV
    Date added:
    11/20/2023
    Date updated:
    01/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Lipella Pharmaceuticals
    Topic:
    Consultant on lichen plans
    Date added:
    11/20/2023
    Date updated:
    01/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    K PHARMACEUTICALS
    Topic:
    Consultant on dry mouth
    Date added:
    11/20/2023
    Date updated:
    01/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Afyx Therapeutics
    Topic:
    Leukoplakia
    Date added:
    01/26/2024
    Date updated:
    01/26/2024
  • Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Mureva
    Topic:
    Oral mucositis (research support)
    Date added:
    01/26/2024
    Date updated:
    01/26/2024
  • Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    Research support
    Date added:
    01/26/2024
    Date updated:
    01/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Uptodate
    Topic:
    Royalties
    Date added:
    01/26/2024
    Date updated:
    01/26/2024
Return to 2024 HPV Elimination Leading Progress Statewide (HELPS) Annual Summit